Research ArticleAccepted Article
Open Access
Sjögren’s syndrome in Systemic Lupus Erythematosus - a subset characterized by a systemic inflammatory state
Guillermo Ruacho, Marika Kvarnström, Agneta Zickert, Vilija Oke, Johan Rönnelid, Susanna Eketjäll, Kerstin Elvin, Iva Gunnarsson and Elisabet Svenungsson
The Journal of Rheumatology September 2019, jrheum.190250; DOI: https://doi.org/10.3899/jrheum.190250
Guillermo Ruacho
The Swedish Research Council (grant no: 2014-33867), Swedish Heart- Lung Foundation (grants no: 20130430, 20130552,20170257), Stockholm County Council (ALF, grants no: 2014016, 20170038), The King Gustaf V 80th Birthday Fund (grant no FAI- 2017-0390), The Swedish Rheumatism Association (grants no: R-739631), Karolinska Institutet´s Foundations, The Swedish Society of Medicine, Ingegerd Johansson´s foundation (SLS-713911). The Swedish Dental Society, Clinical Research grants from Sörmland’s county (no: DLL-614351, DLL-648991), Susanna Eketjäll is an employee at AstraZeneca, and Astra Zeneca provided reagents for the cytokine analyses, but AstraZeneca had no impact on the analyses or on of the presentations in this manuscript. Address correspondence to Elisabet Svenungsson Department of Medicine Solna, Unit of Rheumatology D2:01 Karolinska Institutet SE-171 76 Stockholm, Sweden Email: elisabet.svenungsson@ki.se
Marika Kvarnström
The Swedish Research Council (grant no: 2014-33867), Swedish Heart- Lung Foundation (grants no: 20130430, 20130552,20170257), Stockholm County Council (ALF, grants no: 2014016, 20170038), The King Gustaf V 80th Birthday Fund (grant no FAI- 2017-0390), The Swedish Rheumatism Association (grants no: R-739631), Karolinska Institutet´s Foundations, The Swedish Society of Medicine, Ingegerd Johansson´s foundation (SLS-713911). The Swedish Dental Society, Clinical Research grants from Sörmland’s county (no: DLL-614351, DLL-648991), Susanna Eketjäll is an employee at AstraZeneca, and Astra Zeneca provided reagents for the cytokine analyses, but AstraZeneca had no impact on the analyses or on of the presentations in this manuscript. Address correspondence to Elisabet Svenungsson Department of Medicine Solna, Unit of Rheumatology D2:01 Karolinska Institutet SE-171 76 Stockholm, Sweden Email: elisabet.svenungsson@ki.se
Agneta Zickert
The Swedish Research Council (grant no: 2014-33867), Swedish Heart- Lung Foundation (grants no: 20130430, 20130552,20170257), Stockholm County Council (ALF, grants no: 2014016, 20170038), The King Gustaf V 80th Birthday Fund (grant no FAI- 2017-0390), The Swedish Rheumatism Association (grants no: R-739631), Karolinska Institutet´s Foundations, The Swedish Society of Medicine, Ingegerd Johansson´s foundation (SLS-713911). The Swedish Dental Society, Clinical Research grants from Sörmland’s county (no: DLL-614351, DLL-648991), Susanna Eketjäll is an employee at AstraZeneca, and Astra Zeneca provided reagents for the cytokine analyses, but AstraZeneca had no impact on the analyses or on of the presentations in this manuscript. Address correspondence to Elisabet Svenungsson Department of Medicine Solna, Unit of Rheumatology D2:01 Karolinska Institutet SE-171 76 Stockholm, Sweden Email: elisabet.svenungsson@ki.se
Vilija Oke
The Swedish Research Council (grant no: 2014-33867), Swedish Heart- Lung Foundation (grants no: 20130430, 20130552,20170257), Stockholm County Council (ALF, grants no: 2014016, 20170038), The King Gustaf V 80th Birthday Fund (grant no FAI- 2017-0390), The Swedish Rheumatism Association (grants no: R-739631), Karolinska Institutet´s Foundations, The Swedish Society of Medicine, Ingegerd Johansson´s foundation (SLS-713911). The Swedish Dental Society, Clinical Research grants from Sörmland’s county (no: DLL-614351, DLL-648991), Susanna Eketjäll is an employee at AstraZeneca, and Astra Zeneca provided reagents for the cytokine analyses, but AstraZeneca had no impact on the analyses or on of the presentations in this manuscript. Address correspondence to Elisabet Svenungsson Department of Medicine Solna, Unit of Rheumatology D2:01 Karolinska Institutet SE-171 76 Stockholm, Sweden Email: elisabet.svenungsson@ki.se
Johan Rönnelid
The Swedish Research Council (grant no: 2014-33867), Swedish Heart- Lung Foundation (grants no: 20130430, 20130552,20170257), Stockholm County Council (ALF, grants no: 2014016, 20170038), The King Gustaf V 80th Birthday Fund (grant no FAI- 2017-0390), The Swedish Rheumatism Association (grants no: R-739631), Karolinska Institutet´s Foundations, The Swedish Society of Medicine, Ingegerd Johansson´s foundation (SLS-713911). The Swedish Dental Society, Clinical Research grants from Sörmland’s county (no: DLL-614351, DLL-648991), Susanna Eketjäll is an employee at AstraZeneca, and Astra Zeneca provided reagents for the cytokine analyses, but AstraZeneca had no impact on the analyses or on of the presentations in this manuscript. Address correspondence to Elisabet Svenungsson Department of Medicine Solna, Unit of Rheumatology D2:01 Karolinska Institutet SE-171 76 Stockholm, Sweden Email: elisabet.svenungsson@ki.se
Susanna Eketjäll
The Swedish Research Council (grant no: 2014-33867), Swedish Heart- Lung Foundation (grants no: 20130430, 20130552,20170257), Stockholm County Council (ALF, grants no: 2014016, 20170038), The King Gustaf V 80th Birthday Fund (grant no FAI- 2017-0390), The Swedish Rheumatism Association (grants no: R-739631), Karolinska Institutet´s Foundations, The Swedish Society of Medicine, Ingegerd Johansson´s foundation (SLS-713911). The Swedish Dental Society, Clinical Research grants from Sörmland’s county (no: DLL-614351, DLL-648991), Susanna Eketjäll is an employee at AstraZeneca, and Astra Zeneca provided reagents for the cytokine analyses, but AstraZeneca had no impact on the analyses or on of the presentations in this manuscript. Address correspondence to Elisabet Svenungsson Department of Medicine Solna, Unit of Rheumatology D2:01 Karolinska Institutet SE-171 76 Stockholm, Sweden Email: elisabet.svenungsson@ki.se
Kerstin Elvin
The Swedish Research Council (grant no: 2014-33867), Swedish Heart- Lung Foundation (grants no: 20130430, 20130552,20170257), Stockholm County Council (ALF, grants no: 2014016, 20170038), The King Gustaf V 80th Birthday Fund (grant no FAI- 2017-0390), The Swedish Rheumatism Association (grants no: R-739631), Karolinska Institutet´s Foundations, The Swedish Society of Medicine, Ingegerd Johansson´s foundation (SLS-713911). The Swedish Dental Society, Clinical Research grants from Sörmland’s county (no: DLL-614351, DLL-648991), Susanna Eketjäll is an employee at AstraZeneca, and Astra Zeneca provided reagents for the cytokine analyses, but AstraZeneca had no impact on the analyses or on of the presentations in this manuscript. Address correspondence to Elisabet Svenungsson Department of Medicine Solna, Unit of Rheumatology D2:01 Karolinska Institutet SE-171 76 Stockholm, Sweden Email: elisabet.svenungsson@ki.se
Iva Gunnarsson
The Swedish Research Council (grant no: 2014-33867), Swedish Heart- Lung Foundation (grants no: 20130430, 20130552,20170257), Stockholm County Council (ALF, grants no: 2014016, 20170038), The King Gustaf V 80th Birthday Fund (grant no FAI- 2017-0390), The Swedish Rheumatism Association (grants no: R-739631), Karolinska Institutet´s Foundations, The Swedish Society of Medicine, Ingegerd Johansson´s foundation (SLS-713911). The Swedish Dental Society, Clinical Research grants from Sörmland’s county (no: DLL-614351, DLL-648991), Susanna Eketjäll is an employee at AstraZeneca, and Astra Zeneca provided reagents for the cytokine analyses, but AstraZeneca had no impact on the analyses or on of the presentations in this manuscript. Address correspondence to Elisabet Svenungsson Department of Medicine Solna, Unit of Rheumatology D2:01 Karolinska Institutet SE-171 76 Stockholm, Sweden Email: elisabet.svenungsson@ki.se
Elisabet Svenungsson
The Swedish Research Council (grant no: 2014-33867), Swedish Heart- Lung Foundation (grants no: 20130430, 20130552,20170257), Stockholm County Council (ALF, grants no: 2014016, 20170038), The King Gustaf V 80th Birthday Fund (grant no FAI- 2017-0390), The Swedish Rheumatism Association (grants no: R-739631), Karolinska Institutet´s Foundations, The Swedish Society of Medicine, Ingegerd Johansson´s foundation (SLS-713911). The Swedish Dental Society, Clinical Research grants from Sörmland’s county (no: DLL-614351, DLL-648991), Susanna Eketjäll is an employee at AstraZeneca, and Astra Zeneca provided reagents for the cytokine analyses, but AstraZeneca had no impact on the analyses or on of the presentations in this manuscript. Address correspondence to Elisabet Svenungsson Department of Medicine Solna, Unit of Rheumatology D2:01 Karolinska Institutet SE-171 76 Stockholm, Sweden Email: elisabet.svenungsson@ki.se
Article Figures & Data
Additional Files
Data Supplement
In this issue
The Journal of Rheumatology
Vol. 51, Issue 3
1 Mar 2024
Accepted manuscript
Sjögren’s syndrome in Systemic Lupus Erythematosus - a subset characterized by a systemic inflammatory state
Guillermo Ruacho, Marika Kvarnström, Agneta Zickert, Vilija Oke, Johan Rönnelid, Susanna Eketjäll, Kerstin Elvin, Iva Gunnarsson, Elisabet Svenungsson
The Journal of Rheumatology Sep 2019, jrheum.190250; DOI: 10.3899/jrheum.190250
Accepted manuscript
Sjögren’s syndrome in Systemic Lupus Erythematosus - a subset characterized by a systemic inflammatory state
Guillermo Ruacho, Marika Kvarnström, Agneta Zickert, Vilija Oke, Johan Rönnelid, Susanna Eketjäll, Kerstin Elvin, Iva Gunnarsson, Elisabet Svenungsson
The Journal of Rheumatology Sep 2019, jrheum.190250; DOI: 10.3899/jrheum.190250